
When new vaccines enter the market, health care providers and patients always have questions about what to do.
When new vaccines enter the market, health care providers and patients always have questions about what to do.
Emergency department (ED) visits in the United States for opioid overdoses are up, signaling that the epidemic is worsening, according to a recent CDC report.
In oral testimony before the US House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, FDA Commissioner Scott Gottlieb, MD, urged immediate steps that can be taken to enhance the product of existing licensed influenza vaccines.
These are some of the top foods that may seem 'healthy, but can sabotage your nutrition efforts.
Cigna Corporation and Express Scripts have announced an agreement in which Cigna will purchase the pharmacy benefit manager (PBM) for $67 billion, which includes $15 billion in Express Scripts debt.
In the first and second parts of 'Back to School,' we learned how pharmacy school has changed over the years. In Part 3, we talk to current PharmD student Eric Kinney.
Back by popular demand, we talk to more hardworking pharmacists with fascinating side hustles.
Medical schools are working to bring AR and VR technology into the classroom. Could pharmacy do the same?
Obesity has been considered a risk factor for severe acute respiratory illness, including more severe cases of the flu, but a recently-published study found that weight may not be associated with increased illness severity.
Pharmacists are exposed to increasing job stress. Why does that matter?
March is National Sleep Awareness Month, and pharmacists can help patients get their rest.
Many small health start-ups are leveraging digital health and telemedicine services to provide patient coaching. A new study from one company demonstrates that users could see as much as a 0.8% reduction in A1c.
The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.
Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age).
The online retailing giant has its own brand of nonprescription drugs. Can it compete?
Talk to your patients about alternative therapy with these tips
The past decade has seen a large change in the field of pharmacy, with many companies changing the landscape with new mergers and acquisitions.
Looking to get their data into clinician hands, Higi has teamed up with Rush to get their data into institutions using Epic's EHRs.
More smart inhalers are coming to the US market and pharmacists may see them soon.
Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.
Getting to your medical appointment can be a pain, so why not call on Uber or Lyft? Well, soon you'll get your chance.
A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.
The IDSA and SHEA have made a recent update to the previously published practice guidelines for CDI. While many of the recommendations remain the same, there are a few key changes that the update has addressed.
Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care.
Are you a busy professional? Think eating healthy is difficult? It doesn't have to be!
Opioid allergies are often misdiagnosed. Improper allergy diagnosis may lead to delays in treatment and unnecessary drug avoidance.
Patients with cell phones at the pharmacy is a growing issue.
An international team of respiratory disease specialists looked back at 2017 and assembled a review of the current approaches to asthma and chronic obstructive pulmonary disease.
Technology is great when it works, but in this case, the issue of recieving the wrong amount of insulin can be problematic.
Sanofi recently announced that the FDA has accepted the supplemental Biologics License Application (sBLA) of dupilumab (Dupixent) for the maintenance treatment of asthma.